2 most recent filings and news items mentioning NRX. Updated every 60 seconds.
OfferingJun 4, 2026Neutral
NRX Pharmaceuticals entered into an underwriting agreement with BTIG LLC to sell 5.7 million common shares with a 857,142 share overallotment option. The offering is registered under a Form S-3 shelf registration statement and represents a capital raise for the biopharmaceutical
View filing at SEC.gov →
OtherJun 2, 2026Positive
NexPoint Diversified Real Estate Trust filed its 2026 Long Term Incentive Plan to attract and retain trustees, officers, and key employees through equity and cash-based incentives. The plan establishes a framework for awarding restricted shares, appreciation rights, and cash ince
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.